The Manufacturers Life Insurance Company bought a new position in Maximus, Inc. (NYSE:MMS – Free Report) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor bought 48,438 shares of the health services provider’s stock, valued at approximately $2,604,000.
Several other hedge funds have also modified their holdings of MMS. Farther Finance Advisors LLC lifted its position in Maximus by 69.0% during the 4th quarter. Farther Finance Advisors LLC now owns 284 shares of the health services provider’s stock worth $25,000 after acquiring an additional 116 shares in the last quarter. Advisory Services Network LLC acquired a new stake in Maximus in the third quarter valued at approximately $32,000. Canada Pension Plan Investment Board acquired a new stake in Maximus in the second quarter valued at approximately $35,000. Northwestern Mutual Wealth Management Co. raised its stake in shares of Maximus by 225.2% during the fourth quarter. Northwestern Mutual Wealth Management Co. now owns 439 shares of the health services provider’s stock valued at $38,000 after purchasing an additional 304 shares during the period. Finally, Global Retirement Partners LLC acquired a new position in shares of Maximus during the second quarter worth $40,000. 97.21% of the stock is currently owned by hedge funds and other institutional investors.
Wall Street Analysts Forecast Growth
Several brokerages have recently weighed in on MMS. Zacks Research downgraded shares of Maximus from a “hold” rating to a “strong sell” rating in a research note on Tuesday, August 11th. Wall Street Zen downgraded shares of Maximus from a “buy” rating to a “hold” rating in a research note on Saturday, August 8th. Finally, Weiss Ratings reiterated a “hold (c-)” rating on shares of Maximus in a report on Monday, August 17th. One investment analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, Maximus presently has an average rating of “Reduce”.
Maximus Price Performance
MMS stock opened at $57.67 on Thursday. The company has a market capitalization of $3.02 billion, a PE ratio of 8.52 and a beta of 0.59. The company has a quick ratio of 2.42, a current ratio of 2.42 and a debt-to-equity ratio of 0.90. The stock’s 50 day moving average is $57.78 and its two-hundred day moving average is $63.16. Maximus, Inc. has a 52-week low of $52.73 and a 52-week high of $100.00.
Maximus (NYSE:MMS – Get Free Report) last released its quarterly earnings results on Thursday, August 6th. The health services provider reported $2.22 earnings per share for the quarter, topping analysts’ consensus estimates of $2.21 by $0.01. The business had revenue of $1.28 billion during the quarter, compared to the consensus estimate of $1.33 billion. Maximus had a net margin of 7.07% and a return on equity of 24.91%. The business’s quarterly revenue was down 5.1% compared to the same quarter last year. During the same quarter last year, the company earned $2.16 earnings per share. Maximus has set its FY 2026 guidance at 7.900-8.200 EPS. Analysts predict that Maximus, Inc. will post 8.03 earnings per share for the current fiscal year.
Maximus Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were paid a dividend of $0.33 per share. This represents a $1.32 dividend on an annualized basis and a yield of 2.3%. The ex-dividend date was Friday, August 14th. Maximus’s dividend payout ratio is 19.50%.
Maximus Profile
Maximus, Inc (NYSE: MMS) is a global provider of government services focused on delivering health and human services programs. The company partners with federal, state, and local agencies to administer and manage programs that support individuals and families across various stages of life. Key service areas include eligibility determination and enrollment services for Medicaid, Medicare, Children’s Health Insurance Program (CHIP) and other public assistance programs, as well as call center operations, case management and program integrity solutions.
Further Reading
- Five stocks we like better than Maximus
- Striking Oil: How the U.S. Play for Venezuela Fuels Supermajors
- J.M. Smucker Stock’s Rally Has More Than Tariffs Behind It
- Wendy’s Rally Fades After Trian Steps Back: Was It Ever Real?
- GitLab’s Earnings Beat Just Gave Software Bulls a New SaaSpocalypse Test
Want to see what other hedge funds are holding MMS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Maximus, Inc. (NYSE:MMS – Free Report).
Receive News & Ratings for Maximus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus and related companies with MarketBeat.com's FREE daily email newsletter.
